CIK 0001655759 · Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472566120
- Phone
- 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-23 | Houston John G President and CEO | Grant or award | +124,450 | 1,041,877 | ||
| 2024-02-23 | Houston John G President and CEO | Sale | −5,196 | $47.05 | $244K | 1,036,681 |
| 2024-02-23 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +184,200 | 184,200 | ||
| 2024-02-23 | Cassidy Sean A Chief Financial Officer | Sale | −1,702 | $47.05 | $80K | 181,916 |
| 2024-02-23 | Peck Ronald Chief Medical Officer | Grant or award | +39,250 | 69,215 | ||
| 2024-02-23 | Peck Ronald Chief Medical Officer | Sale | −1,699 | $47.05 | $80K | 67,516 |
| 2024-02-23 | Peck Ronald Chief Medical Officer | Grant or award · Stock Option (right to buy) | +58,100 | 58,100 | ||
| 2024-02-23 | Taylor Ian Chief Scientific Officer | Grant or award | +39,250 | 149,223 | ||
| 2024-02-23 | Taylor Ian Chief Scientific Officer | Sale | −1,701 | $47.05 | $80K | 147,522 |
| 2024-02-23 | Taylor Ian Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +58,100 | 58,100 | ||
| 2024-02-23 | Loomis David K Chief Accounting Officer | Grant or award | +5,750 | 8,500 | ||
| 2024-02-23 | Loomis David K Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +8,750 | 8,750 | ||
| 2024-01-04 | Taylor Ian Chief Scientific Officer | Option exercise | +8,252 | $16.00 | $132K | 109,973 |
| 2024-01-04 | Taylor Ian Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −0 | 10,519 | ||
| 2024-01-04 | Taylor Ian Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −0 | 2,065 | ||
| 2023-11-08 | Loomis David K Chief Accounting Officer | Sale | −229 | $17.05 | $4K | 8,271 |
| 2023-08-11 | Peck Ronald Chief Medical Officer | Option exercise 10b5-1 | +4,010 | 31,289 | ||
| 2023-08-11 | Peck Ronald Chief Medical Officer | Sale 10b5-1 | −1,324 | $24.39 | $32K | 29,965 |
| 2023-08-11 | Peck Ronald Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | −4,010 | 0 | ||
| 2023-06-15 | YOUNG JOHN D Director | Grant or award | +4,121 | 4,121 |
Page 7 of 10 · 184 trades